Department of Clinical Pharmacy and Translational Science, University of Tennessee Health Science Center College of Pharmacy, Memphis, TN, USA.
Department of Pharmacy, Texas Children's Hospital, Houston, TX, USA.
Paediatr Drugs. 2021 Jul;23(4):349-359. doi: 10.1007/s40272-021-00454-2. Epub 2021 May 26.
Lidocaine is an amino amide with a well-established role as a local anesthetic agent. Systemic intravenous administration expands its clinical use to include acute and chronic pain circumstances, such as postoperative pain, neuropathic pain, postherpetic neuralgia, hyperalgesia, visceral pain, and centrally mediated pain. For refractory pain that has not responded to conventional therapy or if further escalation of treatment is prevented by contraindications or side effects to standard therapies, a continuous infusion of lidocaine may be considered as a single intervention or as a sequence of infusions. Here, we review and evaluate published data reflecting the use of lidocaine continuous infusions for pain management in the pediatric population.
利多卡因是一种氨基酸酰胺,作为局部麻醉剂具有明确的作用。静脉内全身给药扩大了其临床用途,包括急性和慢性疼痛情况,如术后疼痛、神经病理性疼痛、带状疱疹后神经痛、痛觉过敏、内脏疼痛和中枢介导的疼痛。对于常规治疗无效的难治性疼痛,或者由于禁忌证或对标准治疗的副作用而无法进一步升级治疗的情况下,可以考虑连续输注利多卡因作为单一干预措施或一系列输注。在这里,我们回顾和评估了反映利多卡因连续输注用于儿科人群疼痛管理的已发表数据。